Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/15/2025

Management of Ventricular Tachycardia

Introduction to Ventricular Tachycardia Management

  • Ventricular tachycardia (VT) is a life-threatening arrhythmia that requires prompt management, with the American Heart Association and the American College of Cardiology providing guidelines for its treatment 1, 2

Pharmacological Management

  • The American Heart Association recommends lidocaine as an alternative to amiodarone, with a dosage of 1-1.5 mg/kg IV bolus, followed by infusion of 1-4 mg/min 1
  • Procainamide can be used as an alternative to amiodarone, with a dosage of 20-50 mg/min IV until arrhythmia suppressed, hypotension occurs, QRS widens by >50%, or maximum dose of 17 mg/kg reached 1
  • The American College of Cardiology recommends continuing oral amiodarone (200-400 mg daily) after IV loading if VT is controlled 1
  • Beta-blockers should be reinstituted as soon as possible after CABG in all heart failure patients without contraindications to reduce the incidence of postoperative atrial fibrillation and improve long-term outcomes, as recommended by the American Heart Association 3
  • Beta-blockers should be continued indefinitely in all patients without contraindications, as recommended by the American Heart Association 3

Post-CABG VT Management

  • Myocardial ischemia is the most common cause of post-CABG VT, according to the American Heart Association 2
  • The American Heart Association recommends considering urgent coronary angiography if suspected graft failure in post-CABG patients with VT 2
  • The American College of Cardiology recommends ensuring ACE inhibitors or ARBs are initiated for patients with reduced LVEF 2
  • Aspirin (75-100 mg daily) should be started as soon as there is no concern about bleeding and continued lifelong after CABG, as recommended by the European Society of Cardiology 4

Device Therapy

  • The American College of Cardiology recommends considering ICD implantation before discharge if VT is due to structural heart disease 2

Antiarrhythmic Medication Selection

  • The American Heart Association recommends avoiding class IC antiarrhythmics (flecainide, propafenone) in post-CABG patients with coronary artery disease 1
  • Ventricular arrhythmias may respond to beta-blockers, lidocaine, procainamide, or amiodarone, as suggested by the Journal of the American College of Cardiology 5
  • Supraventricular tachycardias can be treated with beta-blockers or non-dihydropyridine calcium channel blockers (diltiazem, verapamil), according to the Journal of the American College of Cardiology 5

Monitoring and Supportive Care

  • Continuous ECG monitoring for at least 48 hours after CABG is recommended by the American Heart Association 3
  • Continuous ECG monitoring for at least 48-72 hours post-operatively is recommended to monitor for arrhythmias and other cardiac complications, as suggested by the European Society of Cardiology and the American Heart Association 6, 3
  • Regular assessment of cardiac enzymes and echocardiography to assess ventricular function and mitral regurgitation is essential, to monitor for ongoing ischemia and cardiac dysfunction 6
  • Electrolyte monitoring and replacement (particularly potassium and magnesium) is crucial to reduce arrhythmia risk, as suggested by the European Society of Cardiology 6
  • Target blood glucose <180 mg/dL in the immediate postoperative period, as recommended by the American Heart Association 3
  • Continuous insulin infusion is recommended for the first 24-48 hours, according to the American Heart Association 3

Hemodynamic Management

  • Mean arterial pressure should be maintained >60 mmHg, as recommended by the American Heart Association 3
  • Urine output should be monitored, targeting >0.5 mL/kg/hr, and hemodynamic parameters, including central venous pressure (CVP), cardiac index if PA catheter is in place, and echocardiographic assessment as needed, should be followed 3
  • A multimodal approach with transfusion algorithms and point-of-care testing is recommended by the American Heart Association 3
  • For patients developing low cardiac output syndrome despite adequate fluid resuscitation, positive inotropes and/or vasopressors are recommended as first-line medical treatment, with levosimendan considered to improve survival in patients with perioperative low cardiac output syndrome, as recommended by the British Journal of Anaesthesia 7
  • Dobutamine and milrinone are recommended as first-line inotropes for patients with post-operative low cardiac output syndrome, as suggested by the British Journal of Anaesthesia 7

Fluid Management

  • A restrictive approach to IV fluid management is recommended for patients with normal LV function, with a maintenance rate of 1-1.5 mL/kg/hr, and monitoring central venous pressure and cardiac index if PA catheter is in place, to minimize the risk of fluid overload and post-pump syndrome, as recommended by the American Heart Association 2, 3
  • Initial fluid administration should be guided by hemodynamic parameters, urine output, and clinical signs of adequate perfusion, with a starting rate of approximately 1-1.5 mL/kg/hr for maintenance fluids 3
  • Balanced crystalloid solutions, such as Lactated Ringer's or Plasma-Lyte, are preferred over normal saline for maintenance fluids 3
  • Consider albumin for patients requiring additional volume but at risk for fluid overload, and use colloids judiciously, particularly in patients with renal dysfunction 3

Blood Conservation and Transfusion

  • Strategies to minimize blood loss and transfusion requirements, including the use of lysine analogues, such as tranexamic acid, during and after on-pump CABG, and processing and secondary filtration of red blood cells if shed blood is reinfused, are recommended by the American Heart Association and the British Journal of Anaesthesia 3, 7
  • Consider discarding shed mediastinal blood rather than reinfusing, as recommended by the British Journal of Anaesthesia 7
  • Aggressive blood conservation is indicated to limit hemodilutional anemia and the need for intraoperative and perioperative allogeneic red blood cell transfusion in post-CABG patients, as recommended by the American Heart Association 3

Renal Protection

  • In patients with preexisting renal dysfunction, maintain perioperative hematocrit >19%, consider off-pump CABG technique to reduce risk of acute kidney injury, and minimize use of nephrotoxic agents, as recommended by the American Heart Association 3

Discharge and Follow-up Care

  • Patients with post-pump syndrome should be educated about symptoms of worsening ischemia and when to seek emergency care, and receive sublingual or spray nitroglycerin with proper instructions, and continue medications required to control ischemia after discharge, as recommended by the American College of Cardiology 8
  • Patients with post-pump syndrome should receive regular follow-up care to monitor for cardiac complications and adjust medication management as needed, and blood conservation strategies should be implemented to minimize hemodilutional anemia, as suggested by the American Heart Association 8, 3

REFERENCES